Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Rat models of prenatal and adolescent cannabis exposure.

Dinieri JA, Hurd YL.

Methods Mol Biol. 2012;829:231-42. doi: 10.1007/978-1-61779-458-2_14.

PMID:
22231817
2.

Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome.

Jutras-Aswad D, DiNieri JA, Harkany T, Hurd YL.

Eur Arch Psychiatry Clin Neurosci. 2009 Oct;259(7):395-412. doi: 10.1007/s00406-009-0027-z. Review.

PMID:
19568685
3.

Behavioural consequences of maternal exposure to natural cannabinoids in rats.

Navarro M, Rubio P, de Fonseca FR.

Psychopharmacology (Berl). 1995 Nov;122(1):1-14. Review.

PMID:
8711059
4.

Prenatal cannabis exposure and infant outcomes: overview of studies.

Huizink AC.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:45-52. doi: 10.1016/j.pnpbp.2013.09.014. Review.

PMID:
24075896
5.

Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents.

Campolongo P, Trezza V, Ratano P, Palmery M, Cuomo V.

Psychopharmacology (Berl). 2011 Mar;214(1):5-15. doi: 10.1007/s00213-010-1892-x. Review.

6.

Long lasting consequences of cannabis exposure in adolescence.

Rubino T, Parolaro D.

Mol Cell Endocrinol. 2008 Apr 16;286(1-2 Suppl 1):S108-13. doi: 10.1016/j.mce.2008.02.003. Review.

PMID:
18358595
8.

Molecular mechanisms of maternal cannabis and cigarette use on human neurodevelopment.

Morris CV, DiNieri JA, Szutorisz H, Hurd YL.

Eur J Neurosci. 2011 Nov;34(10):1574-83. doi: 10.1111/j.1460-9568.2011.07884.x. Review.

9.

Issues of risk assessment: lessons from the use and abuse of drugs during pregnancy.

Hutchings DE.

Neurotoxicol Teratol. 1990 May-Jun;12(3):183-9. Review.

PMID:
2164624
10.

Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations.

Campolongo P, Trezza V, Palmery M, Trabace L, Cuomo V.

Int Rev Neurobiol. 2009;85:117-33. doi: 10.1016/S0074-7742(09)85009-5. Review.

PMID:
19607965
11.

Cannabis, the pregnant woman and her child: weeding out the myths.

Jaques SC, Kingsbury A, Henshcke P, Chomchai C, Clews S, Falconer J, Abdel-Latif ME, Feller JM, Oei JL.

J Perinatol. 2014 Jun;34(6):417-24. doi: 10.1038/jp.2013.180. Review.

PMID:
24457255
12.

Neuronal substrates and functional consequences of prenatal cannabis exposure.

Calvigioni D, Hurd YL, Harkany T, Keimpema E.

Eur Child Adolesc Psychiatry. 2014 Oct;23(10):931-41. doi: 10.1007/s00787-014-0550-y. Review.

13.

[Maternal cannabis use and intra-uterine growth restriction].

Davitian C, Uzan M, Tigaizin A, Ducarme G, Dauphin H, Poncelet C.

Gynecol Obstet Fertil. 2006 Jul-Aug;34(7-8):632-7. Review. French.

PMID:
16890472
14.
15.

Adverse effects of cannabis.

[No authors listed]

Prescrire Int. 2011 Jan;20(112):18-23. Review.

PMID:
21462790
16.

Cannabis and the developing brain: insights from behavior.

Trezza V, Cuomo V, Vanderschuren LJ.

Eur J Pharmacol. 2008 May 13;585(2-3):441-52. doi: 10.1016/j.ejphar.2008.01.058. Review.

PMID:
18413273
17.

Adolescent exposure to cannabis as a risk factor for psychiatric disorders.

Rubino T, Zamberletti E, Parolaro D.

J Psychopharmacol. 2012 Jan;26(1):177-88. doi: 10.1177/0269881111405362. Review.

PMID:
21768160
18.

The addictive potential of cannabis.

Kaymak├žalan S.

Bull Narc. 1981;33(2):21-31. Review.

PMID:
6272922
19.

Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia.

Bossong MG, Niesink RJ.

Prog Neurobiol. 2010 Nov;92(3):370-85. doi: 10.1016/j.pneurobio.2010.06.010. Review.

PMID:
20624444
20.

Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure.

Schneider M.

Addict Biol. 2008 Jun;13(2):253-63. doi: 10.1111/j.1369-1600.2008.00110.x. Review.

PMID:
18482434
Items per page

Supplemental Content

Support Center